Crescent Biopharma, Inc. (NASDAQ:CBIO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| M James Barrett Other companies: Senseonics Holdings, Inc. (Director · Mar 17, 2016 – May 30, 2019 · Past); Kineta Inc. (Director · Feb 10, 2016 – Jun 15, 2018 · Past); Zosano Pharma Corp (Director · Jan 26, 2015 – Jan 30, 2015 · Past); Loxo Oncology Inc (Director · Jul 31, 2014 – Jul 28, 2015 · Past); Roka Bioscience Inc (Director · Jul 16, 2014 – Jun 28, 2017 · Past); Omthera Pharmaceuticals Inc (Director · Jul 18, 2013 – Jul 18, 2013 · Past); Supernus Pharmaceuticals, Inc. (Director · Apr 30, 2012 – Mar 16, 2016 · Past); Clovis Oncology Inc (Director · Nov 15, 2011 – Oct 11, 2018 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past); Medimmune Inc (Director · Jun 30, 2006 – Jun 18, 2007 · Past); Pharmion Corp (Director · Jun 8, 2006 – Mar 7, 2008 · Past); Gyre Therapeutics, Inc. (Director · Apr 11, 2006 – Jun 7, 2012 · Past); Inhibitex Inc (Director · Feb 1, 2006 – Feb 13, 2012 · Past); Iomai Corp (Director · Jan 25, 2006 – Aug 4, 2008 · Past) | Director · Jan 9, 2014 – May 18, 2018 · Past |
| David Lubner Other companies: Braveheart Bio, Inc. (Director · Since at least Aug 5, 2026); CARGO Therapeutics, Inc. (Director · Since at least Nov 9, 2023); Arcellx Inc (Director · Since at least Feb 3, 2022); Dyne Therapeutics, Inc. (Board Member · Since at least Jul 31, 2020); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); POINT Biopharma Global Inc (Director · Jul 7, 2020 – Dec 26, 2023 · Past); Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Ra Pharmaceuticals Inc (Executive VP and CFO · Oct 25, 2016 – Apr 2, 2020 · Past); Tetraphase Pharmaceuticals Inc (SVP and CFO · Mar 19, 2013 – Aug 14, 2015 · Past) | Director · Since at least Jun 13, 2025 |
| Peter Harwin Other companies: Damora Therapeutics, Inc. (Chairman of the Board · Since at least Nov 10, 2025); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Cogent Biosciences, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Jul 6, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Jan 22, 2024 · Past); Viridian Therapeutics, Inc. (Director · Oct 27, 2020 – Jun 26, 2024 · Past) | Chair of Board · Since at least Jun 13, 2025 |
| Tomas Kiselak Other companies: Cyclerion Therapeutics, Inc. (Chairman · Since at least Apr 1, 2026); Jade Biosciences, Inc. (Director · Since at least Apr 28, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Viridian Therapeutics, Inc. (Director · Since at least Oct 27, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Sep 27, 2024 · Past) | Director · Since at least Jun 13, 2025 |
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past) | Director · Jul 8, 2014 – May 1, 2024 · Past |
| Jonathan Violin Other companies: Cyclerion Therapeutics, Inc. (Chief Executive Officer · Since at least Apr 1, 2026); Dianthus Therapeutics, Inc. (Director · Since at least Sep 11, 2023); Astria Therapeutics Inc (Director · Since at least Jan 28, 2021); Viridian Therapeutics, Inc. (Chief Executive Officer, Director · Oct 27, 2020 – Feb 2, 2023 · Past); Trevena, Inc. (SVP-Scientific Affairs & IR · Jan 29, 2018 – Feb 28, 2018 · Past) | Director · Since at least Jun 13, 2025 |
| Scott Thomas Jackson Other companies: Mural Oncology plc (Director · Since at least Oct 31, 2023); Spero Therapeutics, Inc. (Director · Since at least Apr 16, 2020); MacroGenics, Inc. (Director · Since at least Jan 24, 2017); Celator Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 14, 2013 – Jul 12, 2016 · Past) | Director · Nov 27, 2018 – May 1, 2024 · Past |
| Timothy R. Pearson Other companies: Korro Bio, Inc. (Director · Since at least Nov 3, 2023); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past); Tesaro Inc (Exec. VP, CFO · May 27, 2014 – Jan 22, 2019 · Past); Catalyst Health Solutions Inc (EVP & Chief Financial Officer · Aug 22, 2011 – Jul 2, 2012 · Past) | Director · Mar 31, 2014 – May 1, 2024 · Past |
| Daniel M. Junius Other companies: IDEXX Laboratories, Inc. (Director · Since at least Mar 11, 2014); Vitae Pharmaceuticals Inc (Director · Jul 27, 2016 – Oct 25, 2016 · Past); ImmunoGen Inc (Director · Jun 8, 2006 – Mar 16, 2018 · Past) | Director · Mar 17, 2016 – May 1, 2024 · Past |
| Joshua Brumm Other companies: Dyne Therapeutics, Inc. (CEO & President, Director · Sep 16, 2020 – Mar 8, 2024 · Past); Kaleido Biosciences, Inc. (See Remarks · Feb 27, 2019 – Mar 4, 2019 · Past); Aravive Inc (COO and CFO · Nov 12, 2015 – Oct 19, 2017 · Past) | Chief Executive Officer · Since at least Jun 13, 2025 |
| Michael A Henos Other companies: Genoptix Inc (Director · Oct 29, 2007 – Feb 25, 2011 · Past); Atherogenics Inc (Director · Apr 26, 2006 – Oct 31, 2008 · Past); Inhibitex Inc (Director · Feb 1, 2006 – Feb 13, 2012 · Past) | Director · Jan 9, 2014 – Jul 15, 2015 · Past |
| Patricia S Andrews Other companies: Geron Corporation (Director · Since at least Mar 25, 2026); Oncolytics Biotech Inc. (Director · Since at least Jan 1, 2026); Incyte Corporation (Chief Commercial Officer · Oct 21, 2008 – Jan 19, 2012 · Past) | Director · Jun 9, 2017 – May 1, 2024 · Past |
| Susan Moran Other companies: Tyra Biosciences, Inc. (Board member · Since at least May 7, 2024); BioAtla, Inc. (Director · Since at least Dec 15, 2020); RayzeBio, Inc. (CHIEF MEDICAL OFFICER · Sep 14, 2023 – Feb 26, 2024 · Past) | Director · Since at least Jun 13, 2025 |
| Harout Semerjian Other companies: Geron Corporation (President and Chief Executive Officer · Since at least Aug 7, 2025); Immunomedics Inc (President and CEO, Director · Apr 16, 2020 – Apr 16, 2020 · Past) | Chief Executive Officer, Director · Aug 6, 2021 – Jan 12, 2024 · Past |
| Helen M Thackray Other companies: ImmunoGen Inc (Director · Sep 22, 2021 – Feb 12, 2024 · Past); BioCryst Pharmaceuticals, Inc. (Chief R&D Officer · Sep 20, 2019 – Mar 31, 2025 · Past) | SVP Clinical Development, CMO · Jan 9, 2014 – Jan 20, 2021 · Past |
| Rachel King Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Nov 12, 2024); Novavax, Inc. (Director · Since at least Oct 31, 2018) | Director · Jan 7, 2016 – May 1, 2024 · Past |
| Richard William Scalzo Other companies: Dyne Therapeutics, Inc. (SVP, Head of Finance & Admin. · Sep 16, 2020 – Mar 11, 2025 · Past); Kaleido Biosciences, Inc. (Principal Accounting Officer · Oct 11, 2019 – Oct 11, 2019 · Past) | Chief Financial Officer · Since at least Jun 13, 2025 |
| Alexandra Balcom Other companies: Nuvalent, Inc. (Chief Financial Officer · Since at least Jul 28, 2021) | Director · Since at least Jun 13, 2025 |
| Chinmaya Rath Other companies: Geron Corporation (Senior Vice President, Chief Business Officer · Since Jul 13, 2026) | SVP and Chief Business Officer · Jan 12, 2024 – Jan 12, 2024 · Past |
| Jonathan McNeill Other companies: Dyne Therapeutics, Inc. (Chief Business Officer · Sep 16, 2020 – Aug 19, 2024 · Past) | President and Chief Operating Officer · Since at least Jun 13, 2025 |
| Ryan Lynch Other companies: Concert Pharmaceuticals Inc (PAO · Jun 15, 2017 – Aug 15, 2019 · Past) | Senior Vice President, Finance and Chief Accounting Officer · Since at least Jun 13, 2025 |
| Scott Koenig Other companies: MacroGenics, Inc. (Director · Since at least Oct 9, 2013) | Director · Mar 9, 2017 – May 1, 2024 · Past |
| Alex Balcom | Until Sep 18, 2026 · Past |
| Amy Reilly | Chief Communications Officer · Since at least Nov 3, 2026 |
| Armand Girard | SVP, Chief Business Officer · Mar 1, 2019 – Nov 11, 2022 · Past |
| Barbara Bispham | General Counsel · Since at least Jun 13, 2025 |
| Brian M Hahn | SVP Finance, CFO · Jan 9, 2014 – Jun 18, 2024 · Past |
| Bruce S Johnson | SVP & Chief Commercial Officer · Mar 23, 2023 – Jan 12, 2024 · Past |
| Chris Doughty | Chief Business Officer · Since at least Nov 4, 2026 |
| Christopher Grant Doughty | Chief Business Officer · Since at least Jun 13, 2025 |
| Edwin Rock | Chief Medical Officer · Sep 2, 2022 – Jun 20, 2024 · Past |
| Ellie Im | Chief Medical Officer · Since at least Jun 22, 2026 |
| Eric Jay Feldman | Chief Medical Officer · Mar 1, 2021 – Mar 1, 2021 · Past |
| Jan Pinkas | Chief Scientific Officer · Since at least Jul 7, 2025 |
| Jenna Poist | Director, Corporate Communications · Since at least Nov 3, 2026 |
| John J Baldwin | Director · Jan 9, 2014 – Jun 29, 2016 · Past |
| John L Magnani | SVP of Research, CSO · Jan 9, 2014 – Nov 11, 2022 · Past |
| Rick Scalzo | Chief Financial Officer · Since at least Jul 31, 2025 |
| Tanya Sengupta | Executive Vice President, Chief of Strategy and Operations · Since at least Jul 31, 2025 |
| Wenjie Cheng | Senior Vice President, Technical Operations · Since at least Nov 4, 2026 |
| William M Gust | Director · Jan 9, 2014 – Jan 15, 2014 · Past |